Glaucoma Drug-Eluting contact lens trial halted after single patient
NCT ID NCT04500574
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a special contact lens that slowly releases the glaucoma drug latanoprost, aiming to replace daily eye drops. Only one person enrolled before the study was stopped early. The goal was to check safety and whether the lens could lower eye pressure, but no conclusions can be drawn from such a small trial.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Massachusetts Eye and Ear
Boston, Massachusetts, 02114, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a bangkok community eye check reveal hidden glaucoma risks?
- AI eye exam: a new hope for early glaucoma detection?
- Can a tiny eye implant replace glaucoma drops?
- Can a new tube implant surgery outperform standard glaucoma surgery?
- Which laser best tames glaucoma pressure?
- Could your personality predict glaucoma drug side effects?